GlassScriptPhysician profile
Cole Wayne Flanagan
NPI 1437169208
$1,984.28
in general payments reported to CMS, 2019-2025
28 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $80.44 · 2021: $146 · 2022: $435 · 2023: $392 · 2024: $288 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.97 | 2019-2024 | |
| Pfizer INC. | $293.59 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $165.13 | 2021-2024 | Exparel |
| Shield Therapeutics INC | $125.26 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $112.96 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $109.03 | 2023-2025 | Veozah |
| Gynesonics, INC. | $98.91 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $95.53 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $77.47 | 2019-2023 | |
| Allergan, INC. | $64.76 | 2019-2020 | |
| Sage Therapeutics, LLC | $45.65 | 2024-2025 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $39.33 | 2019 | |
| Therapeuticsmd, INC. | $35.42 | 2022 | |
| Exact Sciences Corporation | $33.22 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $31.89 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $30.77 | 2022 | |
| Mayne Pharma Commercial LLC | $21.17 | 2023 | |
| Duchesnay USA Incorporated | $20.82 | 2019 | |
| Organon LLC | $20.75 | 2024 | |
| Integra Lifesciences Corporation | $20.39 | 2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Avanos Medical | $17.38 | 2020 | |
| Exeltis, USA INC. | $15.89 | 2024 | Slynd |
| Mimedx Group, INC. | $15.04 | 2025 | |
| Avion Pharmaceuticals | $14.88 | 2023 | Balcoltra |
| Amgen INC. | $14.79 | 2019 | |
| Minerva Surgical, INC | $14.25 | 2023 | |
| Lupin INC. | $14.23 | 2019 | |
| Medtronic, INC. | $13.80 | 2025 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Flanagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.